Vaez et al. gave seventy-two women with polycystic ovary syndrome 500 mg of QRC; then they analyzed serum levels of LH hormone, FSH hormone, and IL-6 [37], and the authors concluded that QRC can decrease inflammatory and LH parameters. The gene discussed is IL6; the disease is polycystic ovary syndrome.